根据美国证券交易委员会(SEC)最新文件显示,脑再生科技(Regencell Bioscience Holdings Ltd)可能通过Univest平台发行普通股,筹资规模最高可达5亿美元。这一举措旨在为公司的生物科技研发及业务拓展注入新动力。
根据美国证券交易委员会(SEC)最新文件显示,脑再生科技(Regencell Bioscience Holdings Ltd)可能通过Univest平台发行普通股,筹资规模最高可达5亿美元。这一举措旨在为公司的生物科技研发及业务拓展注入新动力。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.